☰

Rachel M. Sammons - Publications

Affiliations: 
2011-2018 Chemical Biology and Medicinal Chemistry University of Texas at Austin, Austin, Texas, U.S.A. 
Tree Info Similar researchers PubMed Report error

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Sammons RM, Bohanon AL, Kowtha A, Dejong A, Cho EJ, Kaoud TS, Dalby KN. High-Throughput Assay for Identifying Diverse Antagonists of the Binding Interaction between the ACE2 Receptor and the Dynamic Spike Proteins of SARS-CoV-2. Acs Infectious Diseases. 8: 2259-2270. PMID 36315931 DOI: 10.1021/acsinfecdis.2c00297  0.725
2020 Gagliardi M, Pitner MK, Park J, Xie X, Saso H, Larson RA, Sammons RM, Chen H, Wei C, Masuda H, Chauhan G, Kondo K, Tripathy D, Ueno NT, Dalby KN, et al. Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer. Scientific Reports. 10: 8537. PMID 32444778 DOI: 10.1038/S41598-020-65250-3  0.72
2020 Semba T, Sammons R, Wang X, Xie X, Dalby KN, Ueno NT. JNK Signaling in Stem Cell Self-Renewal and Differentiation. International Journal of Molecular Sciences. 21. PMID 32283767 DOI: 10.3390/Ijms21072613  0.625
2019 Kaoud TS, Johnson WH, Ebelt ND, Piserchio A, Zamora-Olivares D, Van Ravenstein SX, Pridgen JR, Edupuganti R, Sammons R, Cano M, Warthaka M, Harger M, Tavares CDJ, Park J, Radwan MF, et al. Modulating multi-functional ERK complexes by covalent targeting of a recruitment site in vivo. Nature Communications. 10: 5232. PMID 31745079 DOI: 10.1038/S41467-019-12996-8  0.685
2019 Sammons RM, Ghose R, Tsai KY, Dalby KN. Targeting ERK beyond the boundaries of the kinase active site in melanoma. Molecular Carcinogenesis. PMID 31190430 DOI: 10.1002/Mc.23047  0.757
2019 Sammons RM, Perry NA, Li Y, Cho EJ, Piserchio A, Zamora-Olivares DP, Ghose R, Kaoud TS, Debevec G, Bartholomeusz C, Gurevich VV, Iverson TM, Giulianotti M, Houghten RA, Dalby KN. A Novel Class of Common Docking Domain Inhibitors That Prevent ERK2 Activation and Substrate Phosphorylation. Acs Chemical Biology. PMID 31058487 DOI: 10.1021/Acschembio.9B00093  0.82
2019 Kaoud TS, Johnson WH, Ebelt ND, Piserchio A, Zamora-Olivares D, Ravenstein SV, Pridgen JR, Edupuganti R, Sammons R, Cano M, Warthaka M, Ren P, Anslyn EV, Tsai KY, Ghose R, et al. Abstract 3872: Targeting multi-functional ERK-protein complexesin vivo Cancer Research. 79: 3872-3872. DOI: 10.1158/1538-7445.Am2019-3872  0.822
2016 Kaoud TS, Johnson WH, Ebelt ND, Piserchio A, Warthaka M, Cano M, Sammons R, Wang Q, Ren P, Ghose R, Dalby KN. Abstract 3771: Discovery of a covalent inhibitor of ERK docking-interactions that inhibits A375 melanoma cells proliferation Cancer Research. 76: 3771-3771. DOI: 10.1158/1538-7445.Am2016-3771  0.804
2016 Pitner MK, Saso H, Larson R, Sammons RM, Chen H, Wei C, Chauhan G, Kondo K, Ueno NT, Dalby K, Debeb BG, Bartholomeusz C. Abstract 1624: Silencing of ERK2 reverses EMT and suppresses the CSC phenotype, inhibiting lung metastasis in triple-negative breast cancer Cancer Research. 76: 1624-1624. DOI: 10.1158/1538-7445.Am2016-1624  0.654
2015 Sammons RM, Kaoud TS, Devkota AK, Cho EJ, Dalby KN. Abstract 3648: A high-throughput fluorescence anisotropy screening for discovery of inhibitors that target the D-recruitment site of ERK in vitro and in cells Cancer Research. 75: 3648-3648. DOI: 10.1158/1538-7445.Am2015-3648  0.829
2015 Kaoud TS, Xie X, Park J, Tavares CDJ, Mitra S, Cano M, Sammons RM, Radwan MF, Bartholomeusz C, Dalby KN. Abstract 3569: Inhibition of the TRPM7 kinase domain inhibits breast cancer cell migration and invasion and tumor metastasis Cancer Research. 75: 3569-3569. DOI: 10.1158/1538-7445.Am2015-3569  0.764
2013 Xie X, Kaoud TS, Edupuganti R, Sammons RM, Hortobagyi GN, Ueno NT, Dalby KN, Bartholomeusz C. Abstract 3241: Preclinical development of JNK-targeted therapy for triple-negative breast cancer. Cancer Research. 73: 3241-3241. DOI: 10.1158/1538-7445.Am2013-3241  0.761
2012 Kaoud TS, Yan C, Mitra S, Tseng CC, Jose J, Taliaferro JM, Tuohetahuntila M, Devkota A, Sammons R, Park J, Park H, Shi Y, Hong J, Ren P, Dalby KN. From in Silico Discovery to intra-Cellular Activity: Targeting JNK-Protein Interactions with Small Molecules. Acs Medicinal Chemistry Letters. 3: 721-725. PMID 23002419 DOI: 10.1021/Ml300129B  0.751
Show low-probability matches.